公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 74 | 69 | |
2022 | Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome | Wang, Yu-Hung; CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Chia-Lang; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 2 | 2 | |
2011 | The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies | YIN-KAI CHEN ; HSIN-AN HOU ; Chow J.-M.; YEE-CHUN CHEN ; PO-REN HSUEH ; HWEI-FANG TIEN | European Journal of Clinical Microbiology and Infectious Diseases | 40 | 36 | |
2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | CHENG-HONG TSAI ; CHI-YUAN YAO ; FENG-MING TIEN ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | EBioMedicine | 21 | 22 | |
2018 | Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome | HSIN-AN HOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; LIANG-IN LIN ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN | Blood Cancer Journal | 62 | 59 | |
2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 75 | 73 | |
2022 | Interpretation of Biomarkers in Fever of Unknown Origin-demonstration in A Clinical Case | Hsiao, Yu Chung; Sun, Kuo Jui; SZU-MIN HSIEH ; HSIN-AN HOU | Journal of Internal Medicine of Taiwan | 0 | 0 | |
2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
2020 | Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan | Liu Y.; HSIN-AN HOU ; Qiu H.; Tang C.-H. | Scientific Reports | 6 | 5 | |
2012 | A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment | Chou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; MONG-HSUN TSAI ; Chiu Y.-C.; Yu I.-S.; SHU-WHA LIN ; HSIN-AN HOU ; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | PLoS ONE | 20 | 17 | |
2020 | Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice | CHIEN-CHIN LIN ; CHI-YUAN YAO ; Hsu, Yueh-Chwen; HSIN-AN HOU ; CHANG-TSU YUAN ; Li, Yi-Hung; Kao, Chein-Jun; Chuang, Po-Han; Chiu, Yu-Chiao; Chen, Yidong; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Oncogene | 14 | 12 | |
2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
2023 | Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma | Chieh-Lung Cheng ; PO-TING YEH ; Fang, Wei-Quan; WEI-LI MA ; HSIN-AN HOU ; Tsai, Cheng-Hong; CHANG-PING LIN ; HWEI-FANG TIEN | Cancer medicine | 1 | 0 | |
2023 | Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group | Gill, Harinder; Leung, Garret M K; Ooi, Melissa G M; Teo, Winnie Z Y; Wong, Chieh-Lee; Choi, Chul Won; Wong, Gee-Chuan; Lao, Zhentang; Rojnuckarin, Ponlapat; Castillo, Ma Rosario Irene D; Xiao, Zhijian; HSIN-AN HOU ; Kuo, Ming-Chung; Shih, Lee-Yung; Gan, Gin-Gin; CHIEN-CHIN LIN ; Chng, Wee-Joo; Kwong, Yok-Lam | Clinical and experimental medicine | 0 | 0 | |
2008 | Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia | Lee C.-Y.; HWEI-FANG TIEN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN | British Journal of Haematology | 16 | 14 | |
2018 | Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information | Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; JIH-LUH TANG ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; HWEI-FANG TIEN ; HSIN-AN HOU | Mayo Clinic Proceedings | 18 | 19 | |
2020 | MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria | Yassin M.A.; Taher A.; Mathews V.; HSIN-AN HOU ; Shamsi T.; Tuğlular T.F.; Xiao Z.; Kim S.-J.; Depei W.; Li J.; Rippin G.; Sadek I.; Siddiqui A.; Wong R.S. | Cancer Medicine | 29 | 30 | |
2014 | MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia | Ko Y.-C.; WOEI-HORNG FANG ; Lin T.-C.; HSIN-AN HOU ; Chen, Chien-Yuan ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia Research | 10 | 10 | |
2023 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study | Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kiladjian, Jean-Jacques; Granacher, Nikki; Lee, Sung-Eun; Ocroteala, Luminita; Passamonti, Francesco; Harrison, Claire N; Klencke, Barbara J; Ro, Sunhee; Donahue, Rafe; Kawashima, Jun; Mesa, Ruben; HSIN-AN HOU | Lancet (London, England) | 49 | | |
2022 | MPN-545 Surpass-ET: Ropeginterferon Alfa-2b (P1101) vs. Anagrelide as Second Line Therapy in Essential Thrombocythemia | Mesa, Ruben; Komatsu, Norio; Gill, Harinder; Jin, Jie; Lee, Sung-Eun; HSIN-AN HOU ; Sato, Toshiaki; Qin, Albert; Urbanski, Raymond; Shih, Weichung; Zagrijtschuk, Oleh; Zimmerman, Craig; Verstovsek, Srdan | Clinical lymphoma, myeloma & leukemia | 3 | 3 | |